Crosscope inks partnership agreement with Waleed Pharmacy to deliver its AI-enabled digital pathology solutions in Oman

Along with this partnership, Waleed Pharmacy will be an official representative of Crosscope in the Oman region

Crosscope, provider of AI-enabled digital pathology software and Waleed Pharmacy & Stores, an Omar Zawawi Establishment (OMZEST) group company focused on bringing healthcare, hospital, and pharmaceutical solutions to Oman (officially the Sultanate of Oman ), signed a Memorandum of Understanding to enable next-generation transformation in the histopathology landscape using Crosscope AI-enabled digital pathology platform. Together they plan to bring technological solutions to Oman enabling their commercialisation to deliver cancer care, thereby, reducing the cancer burden in Oman.

Along with this partnership, Waleed Pharmacy will be an official representative of Crosscope in the Oman region. Both the organisations intend to bring comprehensive digital pathology platform, AI, and ML tools for cancer diagnostic service providers. They will also explore all the possible avenues for collaboration, working together and leveraging each other’s expertise, network, and know-how to improve the cancer diagnostics landscape in the region.

Dr Jayendra Shinde, CEO, Crosscope said, “We are delighted to join forces with the Waleed Pharmacy group. Waleed Pharmacy’s experienced team has a proven track record of delivering and deploying healthcare IT solutions in the Oman region and represents a perfect partner for Crosscope. By teaming up, we are confident that we have created the synergies to boost the development and commercialisation of our digital pathology workflows.”